Peng Shi

Summary

Country: China

Publications

  1. ncbi Lipid-rich carcinoma of the breast. A clinicopathological study of 49 cases
    Peng Shi
    Department of General Surgery Shandong University Shandong Provincial Hospital, Jinan, 250021, China
    Tumori 94:342-6. 2008
  2. ncbi Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression
    Peng Shi
    Department of General Surgery, Provincial Hospital affiliated to Shandong University, Jinan, Shandong 250021, China
    Chin Med J (Engl) 121:1975-9. 2008

Collaborators

Detail Information

Publications2

  1. ncbi Lipid-rich carcinoma of the breast. A clinicopathological study of 49 cases
    Peng Shi
    Department of General Surgery Shandong University Shandong Provincial Hospital, Jinan, 250021, China
    Tumori 94:342-6. 2008
    ..Lipid-rich carcinoma is a very rare variant of breast cancer with an aggressive clinical course and poor prognosis. The present study aimed to explore its clinicopathologic characters...
  2. ncbi Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression
    Peng Shi
    Department of General Surgery, Provincial Hospital affiliated to Shandong University, Jinan, Shandong 250021, China
    Chin Med J (Engl) 121:1975-9. 2008
    ....